In Practice

First report of clinical presentation of a bite by a running spider, Philodromus sp. (Araneae: Philodromidae), with recommendations for spider bite management

Maureen Coetzee, Ansie Dippenaar, John Frean, Richard H Hunt

Abstract


This article describes the clinical progression of symptoms over a period of 5 days of a bite inflicted by a Philodromus sp. spider. Commonly known as ‘running spiders’, these are not considered to be harmful to humans. This report, however, is the first description of an actual bite by a member of this group of spiders showing cytotoxic envenomation. Management of the bites should be as recommended for other cytotoxic spider bites.


Authors' affiliations

Maureen Coetzee, Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Centre for Emerging, Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa

Ansie Dippenaar, ARC-Plant Protection Research Institute, Pretoria; Department of Entomology/Zoology, University of Pretoria, South Africa

John Frean, Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Centre for Emerging, Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa

Richard H Hunt, Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Centre for Emerging, Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa

Full Text

PDF (129KB)

Keywords

Running spider; Philodromus sp.; Bite; Symptoms

Cite this article

South African Medical Journal 2017;107(7):576-577. DOI:10.7196/SAMJ.2017.v107i7.12422

Article History

Date submitted: 2017-06-30
Date published: 2017-06-30

Article Views

Abstract views: 381
Full text views: 275

Comments on this article

*Read our policy for posting comments here